A Post-Marketing Safety Study using a Pregnancy Registry to Evaluate the Safety of Respiratory Syncytial Virus Vaccine (ABRYSVO™) Exposure During Pregnancy (C3671041)

Study protocol

Initial protocol

C3671041_RSV VACCINE PROTOCOL AMENDMENT 1 V2.0_15MAY2024.pdf

English (309.99 KB - PDF) View document

Updated protocol

C3671041_PROTOCOL AMENDMENT 3 VERSION 4.0_06JAN2026.pdf

First published: 21/01/2026

English (423.54 KB - PDF) View document

C3671041_PROTOCOL AMENDMENT 2 VERSION 3.0_28OCT2025.pdf

First published: 10/12/2025

English (422.7 KB - PDF) View document

Study results

Study report

Other information

Secondary tabs